Lund University is celebrating 350 years. Read more on lunduniversity.lu.se

Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.

A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI.

Author:
  • Sasha Koul
  • Pontus Andell
  • Andreas Martinsson
  • Gustav Smith
  • Fredrik Scherstén
  • Jan Harnek
  • Matthias Götberg
  • Eva Norström
  • Sven Björnsson
  • David Erlinge
Publishing year: 2014
Language: English
Publication/Series: BMC Cardiovascular Disorders
Volume: 14
Document type: Journal article
Publisher: BioMed Central

Abstract english

Despite advances in anti-platelet treatments, there still exists an early increase in both ischemic as well as bleeding events following primary PCI in patients with ST-elevation myocardial infarction (STEMI). Platelet inhibition data of different anti-platelet treatments in the acute phase of a myocardial infarction might offer some insight into these problems. The aim of this study was to evaluate the pharmacodynamic profile of 5 different anti-platelet treatments in the acute phase of STEMI in patients undergoing primary PCI.

Keywords

  • Cardiac and Cardiovascular Systems

Other

Published
  • Clinical Chemistry, Malmö
  • ISSN: 1471-2261
E-mail: gustav.smith [at] med.lu.se

Associate professor

Cardiology

+46 46 17 26 33

D1232C

32

Research project participant

Cardiovascular Epigenetics

32

Research project participant

Heart Failure and Mechanical Support

32

Project manager

Molecular Epidemiology and Cardiology

+46 46 17 26 33

32

Lund University Diabetes Centre, CRC, SUS Malmö, Entrance 72, House 91:12. SE-205 02 Malmö. Telephone: +46 40 39 10 00